Abiopharma

News list

Stansbury Henry Tayloe 🟡 adjusted position in 0 shares (1 derivative) of FAIR ISAAC CORP (FICO) Transaction Date: Aug 22, 2026 | Filing ID: 010850

Full text

News bot Aug. 25, 2026, 9:19 p.m.
🔍 Stansbury Henry Tayloe (Executive)

Company: FAIR ISAAC CORP (FICO)

Report Date: 2026-08-22
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 91
- Total shares sold: 91
Detailed Transactions and Holdings:
- Acquired 91 shares of Common Stock (Direct)
  Date: 2026-08-22 | Code: M | equity_swap_involved: false | shares_owned_after: 351.00 | transaction_form_type: 4
- Sold 91 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-22 | Code: M | Exercise: 2024-08-22 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F2, F3
Footnotes:
- F1: Each restricted stock unit represents a right to receive one share of Fair Isaac common stock contingent upon continued service on the board.
- F2: The restricted stock units vest in three equal annual installments commencing on this date and vested shares will be delivered to the reporting person as soon as practicable thereafter.
- F3: No expiration date.